It was also shown that inhibitors for the DNA repair kinases ataxia telangiectasia mutated (ATM) and DNA-PK restored doxorubicin-induced apoptosis in doxorubicin-resistant APC-deficient breast cancer cells [39]. The gene discussed is ATM; the disease is breast carcinoma.